ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
ArtistPete
|
1.4K |
354K |
27 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.4K
|
354K
|
27
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ArtistPete
|
197 |
34K |
7 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
197
|
34K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints
|
|
ArtistPete
|
132 |
30K |
6 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
132
|
30K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust General Update - Kicking goals
|
|
ArtistPete
|
29 |
5.4K |
17 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
29
|
5.4K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL
|
|
ArtistPete
|
98 |
18K |
20 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
98
|
18K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ArtistPete
|
39 |
10K |
11 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
39
|
10K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Clarification statement
|
|
ArtistPete
|
28 |
9.3K |
14 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
28
|
9.3K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ArtistPete
|
1.4K |
312K |
9 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
1.4K
|
312K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
ArtistPete
|
1.4K |
312K |
13 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
1.4K
|
312K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
ArtistPete
|
194 |
49K |
12 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
194
|
49K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
ArtistPete
|
194 |
49K |
6 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
194
|
49K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
ArtistPete
|
194 |
49K |
14 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
194
|
49K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
ArtistPete
|
194 |
49K |
9 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
194
|
49K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
ArtistPete
|
194 |
49K |
9 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
194
|
49K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Anti-viral Activity Against SARS-CoV-2 Confirmed
|
|
ArtistPete
|
134 |
37K |
7 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
134
|
37K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
RA on AusBisTV Monday 7 Sep at the TH hour
|
|
ArtistPete
|
50 |
11K |
12 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
50
|
11K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Trading halt
|
|
ArtistPete
|
113 |
31K |
4 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
113
|
31K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
RA on AusBisTV Monday 7 Sep at the TH hour
|
|
ArtistPete
|
50 |
11K |
5 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
50
|
11K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
RA on AusBisTV Monday 7 Sep at the TH hour
|
|
ArtistPete
|
50 |
11K |
4 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
50
|
11K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem in partnership to develop waste into fuel technology
|
|
ArtistPete
|
113 |
24K |
6 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
113
|
24K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Organoid Clinical Trial against CoVID-19
|
|
ArtistPete
|
163 |
51K |
4 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
163
|
51K
|
4
|
|
Charts
|
PAA |
Re:
(PAA) TURNING HEADS.
|
|
ArtistPete
|
54 |
15K |
8 |
05/08/20 |
05/08/20 |
Charts
|
54
|
15K
|
8
|
|
ASX - By Stock
|
BCN |
Re:
what are the key expectation from report?
|
|
ArtistPete
|
13 |
3.9K |
0 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
13
|
3.9K
|
0
|
|
ASX - By Stock
|
BCN |
Re:
what are the key expectation from report?
|
|
ArtistPete
|
13 |
3.9K |
1 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
13
|
3.9K
|
1
|
|
ASX - By Stock
|
BCN |
Re:
what are the key expectation from report?
|
|
ArtistPete
|
13 |
3.9K |
3 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
13
|
3.9K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
ArtistPete
|
181 |
39K |
18 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
181
|
39K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Charting PAA
|
|
ArtistPete
|
899 |
202K |
18 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
899
|
202K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Report delivered under Option Agreement
|
|
ArtistPete
|
461 |
92K |
18 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
461
|
92K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
The PAA pattern...
|
|
ArtistPete
|
406 |
291K |
7 |
12/07/20 |
12/07/20 |
ASX - By Stock
|
406
|
291K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
The PAA pattern...
|
|
ArtistPete
|
406 |
291K |
8 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
406
|
291K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
The PAA pattern...
|
|
ArtistPete
|
406 |
291K |
14 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
406
|
291K
|
14
|
|
ASX - By Stock
|
PAA Medicine |
Re:
Clinical Trials
|
|
ArtistPete
|
309 |
77K |
23 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
309
|
77K
|
23
|
|
ASX - By Stock
|
PAA Medicine |
Re:
Clinical Trials
|
|
ArtistPete
|
309 |
77K |
11 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
309
|
77K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Confirmation of Preliminary COVID-19 Results
|
|
ArtistPete
|
380 |
86K |
6 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
380
|
86K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Confirmation of Preliminary COVID-19 Results
|
|
ArtistPete
|
380 |
86K |
8 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
380
|
86K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Confirmation of Preliminary COVID-19 Results
|
|
ArtistPete
|
380 |
86K |
15 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
380
|
86K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Dr Richard Mollard Interview 17 Jul 2020
|
|
ArtistPete
|
42 |
10K |
6 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
42
|
10K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Virtual Investor Briefing Presentation
|
|
ArtistPete
|
148 |
32K |
19 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
148
|
32K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Virtual Investor Briefing
|
|
ArtistPete
|
40 |
12K |
16 |
05/06/20 |
05/06/20 |
ASX - By Stock
|
40
|
12K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary Positive Results for the Treatment of SARS-CoV-2
|
|
ArtistPete
|
285 |
66K |
17 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
285
|
66K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ArtistPete
|
306 |
81K |
7 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
306
|
81K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Roger Aston Interview May 2020
|
|
ArtistPete
|
67 |
17K |
11 |
16/05/20 |
16/05/20 |
ASX - By Stock
|
67
|
17K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Roger Aston Interview May 2020
|
|
ArtistPete
|
67 |
17K |
20 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
67
|
17K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Roger Aston Interview May 2020
|
|
ArtistPete
|
67 |
17K |
11 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
67
|
17K
|
11
|
|
ASX - By Stock
|
PAA |
Roger Aston Interview May 2020
|
|
ArtistPete
|
67 |
17K |
17 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
67
|
17K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome
|
|
ArtistPete
|
438 |
120K |
11 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
438
|
120K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome
|
|
ArtistPete
|
438 |
120K |
9 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
438
|
120K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ArtistPete
|
202 |
63K |
6 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
202
|
63K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
PAA in perspective
|
|
ArtistPete
|
29 |
8.4K |
12 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
29
|
8.4K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4D & Half Year Report
|
|
ArtistPete
|
65 |
1.8M |
15 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
65
|
1.8M
|
15
|
|